D-erythro-Sphingosine, D9

CATALOG # 2079
Amount 1 mg
Price $385.00
Qty
 
D-erythro-Sphingosine, D9
  • Catalog #:2079
  • Scientific Name:D-erythro-Sphingosine, D9
  • Common Name:15,15,16,16,17,17,18,18,18-D9-2-Amino-octadec-4-ene-1,3-diol
  • Empirical Formula:C18H28D9NO2
  • SDSView Safety Data Sheet
  • Data Sheet:View Data Sheet
  • Formula Weight:309
  • Unit:1 mg
  • Solvent:none
  • Source:synthetic
  • Purity:98+%
  • Analytical Methods:TLC, GC, HPLC, identity confirmed by MS
  • Solubility:chloroform, ethanol, methanol, DMSO
  • Physical Appearance:solid
  • Storage:-20°C
  • Dry Ice:No
  • Hazardous:No
  • Literature References:
    1. Magkos, F. and Mittendorfer, B., “Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo” Clin Lipidol. Vol. 4 pp. 215–230, 2009
    2. Byun, H. and Bittman, R. Selective deuterium labeling of the sphingoid backbone: facile syntheses of 3,4, 5-trideuterio-d-erythro-sphingosine and 3- deuterio-d-erythro-sphingomyelin” Chem Phys Lipids, Vol. 163(8) pp. 809-813, 2010
    3. A. Merrill, Jr. “De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway” The Journal of Biological Chemistry, Vol. 277(29) pp. 25843–25846, 2002
    4. J. Shayman “Sphingolipids” Kidney International, Vol. 58 pp. 11-26, 2000
    5. Y. Hannun and R. Bell “Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses.” Vol. 235:4789 pp. 670, 1987
    6. V. Nava et al. “Sphingosine Enhances Apoptosis of Radiation-resistant Prostate Cancer Cells” Cancer Research, Vol. 60 pp. 4468-4474, 2000